TABLE 3.
Possible function in defense of individual DEGs significantly induced at least at one time point of at least at two treatments.
| Gene | Reported function | References |
| AN and DP treatment | ||
| BGL2 | beta 1,3-glucanase, involved in systemic acquired resistance | Durrant and Dong, 2004 |
| AED1 | Apoplastic enhanced disease susceptibility-dependent 1, predicted aspartyl proteases, induced locally and systemically by infection and locally by SA | Breitenbach et al., 2014 |
| SNC4 | Suppressor of NPR1-1, constitutive4 (SNC4) encodes an atypical RLK, involved in plant innate immunity | Bi et al., 2010 |
| DP and AN/DP treatment | ||
| ALD1 | Lys aminotransferase AGD2-like defense response protein 1, required for SAR activation | Song et al., 2004 |
| BON1 | BONZAI1, is a regulator of defense responses apparently through repressing activity of an R gene | Yang et al., 2006 |
| AN and AN/DP treatment | ||
| AOC3 | Allene oxidase cyclase 3, Key gene in JA biosynthesis | Najafi et al., 2020 |
| OPR3 | 12-oxophytodienoate reductase 2- an isoenzyme involved in JA biosynthesis | Schaller et al., 2000 |